Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

An updated approach to determine minimal clinically important differences in idiopathic pulmonary fibrosis

Mohleen Kang, Srihari Veeraraghavan, Greg S. Martin, Jordan A. Kempker
ERJ Open Research 2021 7: 00142-2021; DOI: 10.1183/23120541.00142-2021
Mohleen Kang
Emory University School of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mohleen Kang
  • For correspondence: mkang30@emory.edu
Srihari Veeraraghavan
Emory University School of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Greg S. Martin
Emory University School of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jordan A. Kempker
Emory University School of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jordan A. Kempker
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 7 no. 4
DOI 
https://doi.org/10.1183/23120541.00142-2021

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received March 3, 2021
  • Accepted July 25, 2021
  • Published online October 18, 2021.

Article Versions

  • previous version (August 12, 2021 - 09:12).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright ©The authors 2021 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org

Author Information

  1. Mohleen Kang⇑,
  2. Srihari Veeraraghavan,
  3. Greg S. Martin and
  4. Jordan A. Kempker
  1. Emory University School of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Atlanta, GA, USA
  1. Corresponding author: Mohleen Kang (mkang30{at}emory.edu)
View Full Text

Funding

  • National Heart, Lung, and Blood Institute

    5T32HL116271-07
  • Agency for Healthcare Research and Quality

    K08HS025240

Article usage

Article usage: August 2021 to December 2022

AbstractFullPdf
Aug 20216410826
Sep 2021283210
Oct 202110363126
Nov 2021720792
Dec 2021517578
Jan 20222159110
Feb 202229329
Mar 202239356
Apr 202216419
May 202206541
Jun 202214827
Jul 202255122
Aug 202203723
Sep 202215530
Oct 202207924
Nov 202264326
Dec 202203919

Altmetrics

PreviousNext
Back to top
Vol 7 Issue 4 Table of Contents
ERJ Open Research: 7 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
An updated approach to determine minimal clinically important differences in idiopathic pulmonary fibrosis
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
An updated approach to determine minimal clinically important differences in idiopathic pulmonary fibrosis
Mohleen Kang, Srihari Veeraraghavan, Greg S. Martin, Jordan A. Kempker
ERJ Open Research Oct 2021, 7 (4) 00142-2021; DOI: 10.1183/23120541.00142-2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
An updated approach to determine minimal clinically important differences in idiopathic pulmonary fibrosis
Mohleen Kang, Srihari Veeraraghavan, Greg S. Martin, Jordan A. Kempker
ERJ Open Research Oct 2021, 7 (4) 00142-2021; DOI: 10.1183/23120541.00142-2021
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Supplementary material
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Interstitial and orphan lung disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original research articles

  • Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airways
  • PERSPIRE: a cohort study
  • Ipratropium bromide in EILO
Show more Original research articles

Interstitial lung disease

  • Developing a self-management package for pulmonary fibrosis
  • Development and validation of an ILD exposure questionnaire
  • Effect of nintedanib on AEs of fibrosing ILDs
Show more Interstitial lung disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society